Anti-proliferative effects of paroxetine alone or in combination with sorafenib in HepG2 cells. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 58, 2023. DOI: 10.1590/s2175-97902022e201148. Disponível em: https://revistas.usp.br/bjps/article/view/208137. Acesso em: 19 feb. 2026.